Our analysis demonstrated that LY96 was positively correlated with tumor-promoting immune cells, including M1 macrophages and T cell regulatory Tregs, whereas high LY96 expression was negatively correlated with tumor immune suppression cells, including activated CD4 memory T cells and CD8 T cells. The gene discussed is CD4; the disease is neoplasm.